Engineering Organ-on-a-Chip Systems for Vascular Diseases

Abstract

Vascular diseases, such as atherosclerosis and thrombosis, are major causes of morbidity and mortality worldwide. Traditional in vitro models for studying vascular diseases have limitations, as they do not fully recapitulate the complexity of the in vivo microenvironment. Organ-on-a-chip systems have emerged as a promising approach for modeling vascular diseases by incorporating multiple cell types, mechanical and biochemical cues, and fluid flow in a microscale platform. This review provides an overview of recent advancements in engineering organ-on-a-chip systems for modeling vascular diseases, including the use of microfluidic channels, ECM (extracellular matrix) scaffolds, and patient-specific cells. We also discuss the limitations and future perspectives of organ-on-a-chip for modeling vascular diseases.

Adipose Tissue in Breast Cancer Microphysiological Models to Capture Human Diversity in Preclinical Models

“…Indeed, high-throughput, label-free, live cell imaging of MPS offers the potential to become a foundational tool in future pharmaceutical drug discovery [ 109 ]. In addition, the incorporation of biosensors for readouts in real-time [ 110 , 111 ], as well as the connectors and flow generators in the plates and devices [ 112 , 113 , 114 ], will support the adoption of breast cancer MPS alone or in multi-tissue systems for drug toxicity and efficacy testing in the context of cancer [ 115 , 116 , 117 ].…”

Use of iPSC-Derived Smooth Muscle Cells to Model Physiology and Pathology

“…119 These models have not been extensively utilized for vascular and SMC-driven diseases, yet, but the technology exists, and this is a promising direction for future research. 120…”